Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma.
about
Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Validation of the Pretreatment ...... er Tract Urothelial Carcinoma.
@en
type
label
Validation of the Pretreatment ...... er Tract Urothelial Carcinoma.
@en
prefLabel
Validation of the Pretreatment ...... er Tract Urothelial Carcinoma.
@en
P2093
P2860
P356
P1476
Validation of the Pretreatment ...... per Tract Urothelial Carcinoma
@en
P2093
Geng-Yan Xiong
Guang-Zhi Zhao
Li-Qun Zhou
Xue-Song Li
Zhen-Peng Cao
P2860
P304
P356
10.4103/0366-6999.213414
P407
P50
P577
2017-09-01T00:00:00Z